A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors
The present coronavirus disease 2019 (COVID-19) pandemic scenario has posed a difficulty for cancer treatment. Even under ideal conditions, malignancies like small cell lung cancer (SCLC) are challenging to treat because of their fast development and early metastases. The treatment of these patients...
Main Author: | Babak Sokouti |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2023-10-01
|
Series: | Exploration of Targeted Anti-tumor Therapy |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/etat/Article/1002177 |
Similar Items
-
Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective
by: Nahid Shahabadi, et al.
Published: (2023-01-01) -
Understanding the unusual viral outbreak: Coronavirus disease 2019
by: Tarun Kumar Suvvari, et al.
Published: (2020-01-01) -
Investigating an Emerging Virus During a Sudden Pandemic Outbreak
by: Ronit Sarid
Published: (2020-07-01) -
Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena
by: Arghadip Samaddar, et al.
Published: (2020-09-01) -
Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
by: Omid Kooshkaki, et al.
Published: (2020-10-01)